US Pharma MarketingFDA approves Takeda's orexin drug for narcolepsy
One of the most closely watched commercial drug races is now off and running, after Takeda snagged FDA approval of its orexin agonist to treat narcolepsy type 1. The FDA
One of the most closely watched commercial drug races is now off and running, after Takeda snagged FDA approval of its orexin agonist to treat narcolepsy type 1.
The FDA
Source: Endpoints News